Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03
Nyrada Inc has completed an in-vivo micronucleus on the effects of its NYR-BI03 drug on rats, suggesting it causes no genetic damage
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
DMA | Ann: Results of Annual General Meeting | 22/01/20 | 3 | 2.9K | |||
|
|||||||
DMA | News: DMA ASX Says Dynasty Resources Ltd To Be Removed From Official List Of ASX | 09/12/19 | 0 | 699 | |||
|
|||||||
DMA | Ann: Removal from Official List | 09/12/19 | 0 | 662 | |||
|
|||||||
DMA | Ann: Adoption of New Constitution | 05/12/19 | 0 | 474 | |||
|
|||||||
DMA | Ann: Notice of Annual General Meeting/Proxy Form | 31/10/19 | 0 | 524 | |||
|
|||||||
DMA | Ann: Appendix 4G and Corporate Governance Statement | 31/10/19 | 0 | 455 | |||
|
|||||||
DMA | Ann: Annual Report to shareholders | 31/10/19 | 0 | 636 | |||
|
|||||||
DMA | News: DMA Dynasty Resources Says Co Is Expected To Be Delisted From ASX Official List On 8 Dec | 30/10/19 | 0 | 433 | |||
|
See All Discussions